Loading provider…
Loading provider…
Dermatology Physician in Spring, TX
NPI: 1003342833Primary Practice Location
The Woodlands Dermatology Associates PA
9303 Pinecroft Dr, Spring, TX
Primary Employer
The Woodlands Dermatology Associates PA
woodlandsdermatology.com
HQ Phone
Get MD Andrew's Phone NumberMobile
Get MD Andrew's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardTX State Medical License
TX State Medical License
2021 - 2027

American Board of Dermatology
Dermatology

American Board of Dermatology
Dermatopathology
Texas A&M University
B.S. • Biochemistry and Genetics
2010 - 2013
Baylor University Medical Center
Residency • Dermatology
2018 - 2021
University of Texas Medical Branch Hospitals
Internship • Internal Medicine
2017 - 2018
Fellowship • Dermatopathology
2021 - 2022
UTMB Health
utmb.edu
Medical School
Until 2017
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 88305Pathology examination of tissue using a microscope, intermediate complexity | 1,496 | 2,510 |
| 2 | 99213Established patient office or other outpatient visit, typically 15 minutes | 207 | 230 |
| 3 | 11102Tangential biopsy of single skin lesion | 191 | 214 |
| 4 | 17000Destruction of skin growth | 129 | 148 |
| 5 | 17003Destruction of 2-14 skin growths | 84 | 361 |
Penile calciphylaxis with extragenital gangrene.
Authors: Annika Silfvast-Kaiser, Martin Menter, Marcus Zaayman, Edgar Rodriguez
Journal: Proc (Bayl Univ Med Cent)
Publication Date: 2021-01-28
Normocomplementemic urticarial vasculitis in a young female with persistent joint pain.
Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Intervention / Treatment: DIAGNOSTIC_TEST: DetermaRX
Lead Sponsor: University of Malaya
Intervention / Treatment: DEVICE: Conventional TBA, DEVICE: 3D TBA
Lead Sponsor: Boehringer Ingelheim
Intervention / Treatment: DRUG: Brigimadlin